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Human immunodeficiency virus 1 (HIV-1) affects 
millions of people around the world. One particular strain, 
called HIV-1, infects immune cells such as CD4+ T cells and 
macrophages1. If not treated properly, HIV-1 can develop into 
acquired immunodeficiency syndrome (AIDS) which currently 
has no cure. Due to its aggressive nature and high-replication 
rate, HIV-1 is able to circumvent innate host cellular defense 
mechanisms. In a mature HIV-1 virion, the viral genome and its 
vital accessory proteins and enzymes are housed within a 
conical lattice structure known as the capsid. The capsid is 
composed of a protein shell of monomers called CA protein 
which polymerize to form ~200 hexamers and 12 pentamers per 
fullerene cone. The capsid facilitates infection by interacting 
with multiple host cellular factors while simultaneously 
protecting viral genetic material and thus serves as a therapeutic 
target before the critical step of genome integration. Each CA  
hexamer and pentamer contains an electropositive pore that 
mediates binding with many small negatively charged 
molecules. The charged pore, ringed by a one arginine residue 
per monomer, presents an environment that is known to interact 
with phosphate moieties of inositol hexaphosphate (IP62) and 
deoxynucleoside triphosphate (dNTPs3) which promotes charge 
stability and acts as a nucleotide fuel source for the HIV-1 
enzyme reverse transcriptase. Small molecule binding to capsid 
is a relatively recent discovery and is a field where capsid 
dynamics can be studied. The capsid must maintain a delicate 
balance by remaining stable enough to protect HIV genetic 
material while also being able to break apart to allow cDNA to 
integrate into the host genome. It is important to understand how 
CA hexamer/CA pentamer structure, and by extension that of 
the entire capsid lattice, is affected by small molecule binding, 
which may result in stability changes or larger scale structural 
alterations.  
 
Investigating factors that affect HIV-1 capsid stability 
 
Abstract 
T  HIV ca d, a   c d  c   CA,  a  c  a  c  HIV  a   a d 
enzymes during infection. I am interested in elucidating the factors that influence stability of the capsid shell and capturing the 
structural interactions between HIV capsid, host restriction factors, and small molecules using biochemical and structural biology 
techniques. HIV capsid shell was broken down and purified into hexamer and pentamer units for in vitro study. Structural assays 
were performed using X-ray crystallography and biochemical analysis was performed using pelleting assays. By understanding 
capsid structure with factors that confer stability, treatments can be designed to target the protective HIV capsid before the critical 
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 Using structural biology, which studies the molecular 
structure and dynamics of biological macromolecules, complex 
protein interactions and functions can be studied in vitro. 
Former studies using structure-based crystallography, which 
utilizes fired X-ray beams at a crystalline layer of protein(s) to 
calculate the structure of a molecule from its diffraction pattern, 
have not produced high resolution data. Currently, capsid is 
difficult to visualize on a structural level due to inherent 
shortfalls in CA hexamer structure determination. When solving 
the structure of hexamers, electron density from each CA 
monomer is averaged together due to 6-fold hexameric 
symmetry in order to increase the signal:noise ratio and gain a 
higher resolution model. Since the data is symmetrically 
averaged, anything bound to the hexamer also has its density 
averaged out six-fold2, preempting any useful information of 
asymmetric binding modes of molecules other than CA. IP6, a 
small molecule, is inherently asymmetric with binding that may 
induce slight conformational changes in a hexamer that could 
propagate throughout the lattice of the capsid to trigger larger 
scale stability and structure changes. Previous work in Dr. 
X  ab  a  c a  b d  a , c  a  a a 
nanobodies with cyclophilin A (CypA4), can break the six-fold 
symmetry, potentially allowing for us to visualize any small 
molecules that may bind asymmetrically. By breaking the six-
fold symmetry, we can gain insight into known small molecule 
binding and potentially discover other small molecules/peptides 
that may bind similarly or at other sites.  
 Our lab mimicked the in vitro native capsid through 
disulfide crosslinking technology using established 
mechanisms5. Through the addition of disulfides, we can 
crosslink individual hexamers together, effectively 
recapitulating at least the face of the capsid that binding factors 
see. Previous studies have shown that small molecules, such as 
fasciculation and elongation protein 1 (FEZ1), containing poly-
glutamate binding regions can directly bind to HIV-1 capsid 
hexamer pores9. Molecules such as polyglutamine binding 
protein 1 (PQBP1) and poly-E peptide were investigated with 
hexamer pores due to having similar charged properties as 
FEZ1. Furthermore, IP6 was used as a binding agent to hexamer 
and pentamer pores2. After purification and capsid assembly, 
biochemical and structural studies were performed to continue 
elucidating the molecular details of CA hexamer and CA 
pentamer. Using studies on the regulation and structural stability 
of CA hexamer and CA pentamer presents opportunities to 
develop more rapid and affordable diagnostic tests and drugs 




Culture and Growth 
HIV-1 CA (A14C/E45C; hexamers for tube assembly) 
or (A14C/E45C/W184A/M185A; soluble hexamers) or 
(L21C/N22C/W184A/M185A; soluble pentamers) was cloned 
into pET11a using Nde1/BAMH1 restriction sites and 
transformed into BL21(DE3) cells. Cells were grown at 37oC 
and 200 rpm until OD600 ~0.6-0.8 and induced with 0.5 mM 
IPTG at 25oC for 12 hours. Cells were spun in centrifuge at 5000 
RPM for 10 minutes and pellets were stored at -80oC. 
 
CA Preparation   
Thawed cell pellets were resuspended in 50 mM Tris 
pH8, 300 mM NaCL, 0.2 mM TCEP and a tablet of cOmplete 
Mini, EDTA-free protease inhibitor (Roche). Cells were lysed 
with a microfluidizer at 15000 psi followed by centrifugation 
for 35 minutes at 15000 RPM. Lysate volume was 
proportionally combined with ammonium sulfate to achieve 
25% total volume saturation at 4oC and stirred in cold room for 
2 hours. Lysate mixture was spun 15000 RPM for 20 minutes. 
Supernatant was decanted and remaining pellet was let to 
resuspend in 20 mL of SA buffer (25 mL HEPES pH 6.8, 0.2 
mM TCEP) for 4-5 hours. Once pellet was completely 
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resuspended, resuspension was dialyzed in SA buffer at 4oC 
overnight. The following day, the sample was spun down for 15 
minutes at 15000 rpm and purified using HiTrap SP (GE) ion 
exchange chromatography5. Pentamers preps were identical 
except using a HiTrap Q (GE) column. Purified constructs were 
finished with gel filtration (S200 PG; GE) to ensure protein was 
monodisperse. Protein molecular weight and behavior was 
analyzed using reducing and non-reducing samples on SDS-
PAGE. 
Soluble CA Assembly 
After obtaining uniformly-dispersed CA monomers, 
CA proteins are transferred into a dialyzer cassette and dialyzed 
into 50 mM Tris pH 8, 1M NaCl, and 40 mM BME overnight in 
4oC cold room. The following day, cassette was transferred to 
dialyze in 50 mM Tris, 1M NaCl for two whole days. Finally, 
cassette dialyzed in 50 mM Tris for a day. Following the four-
day assembly process, soluble CA hexamers and pentamers 
became stably cross-linked and ready for analysis (Figure 1).  
 
 
Figure 1.5 Xiong Lab protocol of in vitro engineered capsid 
hexamer design, assembly, and validation. (A.) HIV-1 capsid 
hexamers were recreated in vitro via disulfide linkages at residues 
14 and 45 of CA (A14C/E45C)5. Using reducing and non-reducing 
conditions, hexamers were seen to be composed of monomeric CA 
protein. Through established capsid protocols, whole hexamers 
were created and purified using CA. Hexamer complexes were run 
under reducing and non-reducing gel conditions to reveal dimer, 
trimer, and hexamer species as designed. (B.) Assembly products 
were run on size exclusion chromatography and were well-behaved 
and shown to be monodispersed. Figures obtained from Summer, 
B ad /X , Y  a : Modular HIV-1 Capsid Assemblies 
Reveal Diverse Host-Ca d R c  M c a .  
Biochemical and structural studies were performed 
using a variety of CA assemblies4: 1) insoluble helical CA tubes, 
2) soluble hexamers, created from six CA monomers linked 
together via disulfide bonds, and 3) soluble pentamers, created 
from five CA monomers linked together via disulfide bonds. 
Helical CA tubes, made with cysteine mutations at residues 14 
and 45, mimic the inter-hexamer interfaces on the native capsid. 
After assembly, helical CA tubes labeled CA 
(14C|45C|WM)were used in pelleting assays to test molecular 
binding with selective small molecules. Hexamers were created 
using CA mutant residues at A14C and E45C that were 
engineered previously in Xiong lab and assembled5 (Figure 1). 
The 14C residue of CA forms a disulfide bond with the 45C 
residue of a neighboring CA to provide stability to hexamers in 
vitro. Utilizing alanine mutations prevents the inter-hexamer 
polymerization as seen in the 14C|45C|WM mutant. Hexamer 
mutant constructs were purified and labeled Hexamer 
14C|45C|AA (Hex AA). These hexamers were soluble allowing 
for crystal trays to be set up to characterize their structural 
interactions with other molecules. Similarly, pentamers were 
created through cysteine mutations at residues 21 and 22 of CA 
with residues 21C and 22C of CA forming a disulfide bond to 
provide stability to pentamers in vitro. Pentamer mutant 
constructs were purified and labeled Pentamer 21C|22C|AA 
(Pent AA).   
 Pelleting assay protocol established in Xiong Lab6 was 
used to biochemically assess binding interactions between CA 
tubes and small molecules of interest. The R18 residue of HIV-
1 CA A14C/E45C is a target of interest due to that residue being 
located at the pore, potentially serving as a binding interactor to 
PQBP1 because of glutamate stretches as shown similarly to 
FEZ1  b d  ac    c d c ral pore of 
capsid9.  Pelleting assay takes advantage of the inherent 
insolubility of the tubes. Pelleting assay was conducted using 
CA tubes incubated with PQBP1, a host protein that directly 
interacts with HIV-1 reverse-transcribed DNA and is a crucial 
3
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part of the cGas/IRF3-dependent innate response to HIV7. Using 
maltose-binding protein (MBP) as a negative control, CA tubes 
and mutant CA tubes were incubated with PQBP1. The mutant 
CA tubes were at the R18D residue removing the positively 
charged residue of CA to determine if binding affinity to PQBP1 
was affected. Five reactions were created containing the 
following proteins: 1) MBP, 2) PQBP1, 3) MBP and CA tubes, 
4) PQBP1 and CA tubes, 5) PQBP1 and CA R18D tubes. Gel 
samples were taken from the total incubated sample, the post-
centrifugation soluble sample, and from the resuspended 
insoluble pellet of CA tubes. 
 Purified Hex AA and Pent AA protein were used for 
setting up microbatch under oil crystallization screens with 
various binding partners and small molecules. Hex AA was 
incubated with CypA, llama nanobody, and IP6. Pent AA 
crystallization trays were set up in three different forms: 1) Pent 
AA in Apo-form (Pent AA Apo) at 37.5 uM, 2) Pent AA with 
CypA at 75 uM, and 3) Pent AA with IP6 at 37.5 uM. Protein 
solutions were made with proteins of interest and gel filtration 
buffer (50 mM Tris pH8 and 75 mM NaCl). Crystallization was 
tested with premade matrix screens including various salt, 
buffer, and precipitating agents of polyethylene glycol (PEG). 
The following matrix screens used were NeXtal Classics, 
Classics Lite, JCSG+, ProComp, and PACT. Crystal trays were 
initially set up under standard laboratory protocols4, 5, 6 using a 
paraffin:silicon oil ratio of 2:1 and a protein:condition solution 
ratio of 1 µL:1 µL. After obtaining initial crystallization hits, 
matrix screens were optimized through varying concentrations 
of protein:condition ratios followed by pH screen optimization 
and optimization of precipitating agent. Initial crystallization 
hits were serially seeded into optimized conditions. Protein 
content verified using light microscopy/birefringent lens, 
absorption of Coomassie Brilliant Blue dye, ultraviolet 




 Following established purification and assembly 
protocols, in vitro native capsid hexamers and pentamers were 
successfully produced. The CA monomer has a molecular 
weight of 25 kDa and when in its assembled hexamer 
configuration, the molecular weight expected is 150 kDa. Non-
reducing and reducing gel samples of Hex AA indicated that the 
species was indeed in the right assembled form with a non-
reducing band at 150 kDa and reducing at 25 kDa, indicating 
that all disulfide crosslinks were reduced to form component 
monomers. Hex AA species also showed high purity via SDS-
PAGE (Figure 2). Pent AA constructs were validated through 
the same process.  
 
 
Figure 2. Hexamer AA Purification Validation. (A.) Non-reducing 
and reducing samples of Hex AA from GF were run on SDS-PAGE 
to identify the molecular weight of the species. (B.) Post-assembly 
and purification, Hex AA was run on size-exclusion 
chromatography/gel filtration column (GF) and showed a uniform, 
monodispersed peak at the expected retention volume.  
 
Biochemical Assay 
Soluble proteins such as MBP and PQBP1 were expected to 
have higher band density in the soluble gel sample and lesser 
band density in the pellet gel sample if no significant binding 
with CA tubes were present. Total, soluble, and pellet fractions 
were analyzed using SDS-PAGE. Pellet samples show 
4
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relatively equal amounts of CA tubes loaded along with equal 
inputs of MBP and PQBP1 (Figure 3). Negative control of MBP 
was used as a loading control and was known to have no binding 
interactions to CA WM/CA R18D. The R18D residue is of 
interest due to its location in the central pore of capsid. Soluble 
gel sample appears to show as much PQBP1 protein in 
supernatant as when PQBP1 was incubated with CA R18D 
tubes, indicating loss of binding for PQBP1 with the CA R18D 
tubes. Pellet gel sample shows CA tubes have highest binding 
affinity to PQBP1, followed by a faint band density for CA 
R18D tubes. This experiment showed that PQBP1 had a 
substantial reduction in its binding affinity to CA tubes when 
the R18D mutation was made (Figure 3).  
 
 
Figure 3. Pelleting assay of CA (WM) tubes/CA R18D tubes with 
MBP/PQBP1. Total sample (Input) refers to samples taken from 
the pelleting tubes post-incubation of proteins. Soluble sample 
(Sup) refers to samples taken of the supernatant from the pelleting 
tubes post-centrifugation at 14,500 rpm for 15 minutes at 4oC. 
Pellet sample refers to samples taken from the pelleting tubes after 
removing supernatant, leaving the insoluble CA tubes with 
potentially bound proteins. Total, soluble, and pellet fractions were 




Crystallization hits were obtained from varying matrix 
screens of ProComp, PACT, and JCSG+. Initial crystal hit of 
Hex AA with CypA, llama nanobody, and IP6 in ProComp 
(0.2M Sodium Acetate, 0.1M Sodium Citrate pH 5.5, 10% 
Polyethylene Glycol 4000) was optimized through varying 
stoichiometric protein concentration ratios4 (ranging from 1x to 
12x) between CypA and Llama nanobody which improved 
crystal lattice structure and created more ordered protein 
crystals under the same ProComp conditions (Figure 4). Higher 
resolution crystals from the optimization screen were looped out 
and sent for x-ray crystallographic data collection. Crystals were 
cryoprotected with 25% ethylene glycol solutions before frozen 
in liquid nitrogen. Diffraction data was collected at NE-CAT 
beamline 24ID-C at the Advanced Photon Source. Diffraction 
data collected at a resolution of ~7Å was not at a high enough 
resolution to observe interactions of interest (Figure 4). 
Crystallization hit from Hex AA with poly-E peptide diffracted 
at a high-resolution of ~3.5Å (Figure 5).  
 
Figure 4. Crystallization using microbatch under oil in ProComp 
conditions (0.2M Sodium Acetate, 0.1M Sodium Citrate pH 5.5, 
10% Polyethylene Glycol 4000) for Hex AA, IP6, llama nanobody, 
and CypA. Initial screen refers to standard ProComp conditions 
with a ratio of 1:1 for CypA and nanobody. Optimization screen 
refers to varying stoichiometric protein ratios between 1x-12x for 
CypA and nanobody concentrations while keeping ProComp 
conditions same. Crystals observed under light microscopy and 
photographed. Pictures formatted on Microsoft PowerPoint. 
 
 
Figure 5. Crystallization using microbatch under oil for Hex AA 
5
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and poly-E peptide. Crystals observed under light microscopy and 
photographed. Pictures formatted on Microsoft PowerPoint. 
 
Pentamer Crystals 
Crystallization hits were obtained from varying matrix 
screens of JCSG+, PACT, and ProComp. Initial crystal hits in 
PACT, JCSG+, and ProComp were serially seeded into the same 
conditions and observed. JCSG+ screens failed to reproduce 
crystals and were not pursued for further analysis with Pent AA. 
 
Pent AA (APO) 
Post-serial seeding, ratio optimizations of 
protein:condition solution ranging from 0.25x to 3x were 
performed in matrix screen hits of ProComp (0.1M Magnesium 
Chloride, 0.1M HEPES pH7, and 15% Polyethylene Glycol 
4000; 0.2M Ammonium Sulfate, 0.1M MES pH 6.5, and 20% 
Polyethylene Glycol 8000) and PACT (0.2M 
Sodium/Potassium Phosphate and 20% Polyethylene Glycol 
3350) (Figure 6). PACT solutions produced jagged, non-
uniform and heterogeneous crystals. ProComp condition (0.2M 
Ammonium Sulfate 0.1M MES pH 6.5, and 20% Polyethylene 
Glycol 8000) produced the most uniform crystals out of the Pent 
AA Apo hits. Pent AA Apo hits generally precipitated crystals 
within 6 days of setting up crystallization trays (Figure 6). 
 
 
Figure 6. Pent AA (Apo) crystallization using microbatch under oil 
in ProComp conditions (0.2M Sodium Acetate, 0.1M MES pH 6.5, 
20% Polyethylene Glycol 8000). (A.) Left image shows bottom of 
microbatch under oil drop. (B.) Right image shows surfa view ce 
of same drop. Crystals observed under light microscopy and 
photographed. Pictures formatted on Microsoft PowerPoint. 
Pent AA with CypA  
Initial crystallization hits were in PACT screens (0.2M 
Sodium Iodide, 0.1M Bis Tris Propane pH 7.5, and 20% 
Polyethylene Glycol 3350; 0.2M Sodium Iodide, 0.1M Bis Tris 
propane pH 8.5, and 20% Polyethylene Glycol 3350) and 
ProComp (0.1M MES pH 6.5 and 15% Polyethylene Glycol 550 
MME; 0.1M Magnesium Chloride, 0.1M HEPES pH 7.5, and 
10% Polyethylene Glycol 4000). Initial hits were serially seeded 
into crystal condition hits. Post-serial seeding, ratio 
optimizations of protein:condition solution ranging from 0.25x 
to 3x were performed in matrix screen hits of PACT and 
ProComp. PACT failed to reproduce initial crystallization hits 
with Pent AA CypA. ProComp condition 0.1M HEPES pH 7.5, 
and 10% Polyethylene Glycol 4000 produced the most uniform, 
singular crystals post-ratio optimization. Pent AA with CypA 
hits generally precipitated crystals within 30 days of setting up 
crystallization trays. 
 
Pent AA with IP6 
Initial crystallization hits were in ProComp screen 
(0.1M Sodium Citrate pH 5 and 8% Polyethylene Glycol 8000) 
and PACT screens (0.2M Sodium Chloride, 0.1M MES pH 6, 
and 20% Polyethylene Glycol 6000; 0.2M Magnesium 
Chloride, 0.1M HEPES pH 7, and 20% Polyethylene Glycol 
6000) (Figure 7). Initial hits were serially seeded into crystal 
condition hits. Post-serial seeding, ratio optimizations of 
protein:condition solution ranging from 0.25x to 3x were 
performed in matrix screen hits of PACT and ProComp. 
Optimized crystal hits from PACT 0.2M Magnesium Chloride, 
0.1M HEPES pH 7, and 20% Polyethylene Glycol 6000 
produced the most uniform and singular crystals. Ratio 
optimization was followed by HEPES pH gradient from 6.0 to 
pH 8.0 (in increments of 0.2 pH) and percent precipitating agent 
(10%, 20%, 30% PEG 6000) in combination with standard 0.2M 
MgCl2. Optimal pH was determined to be 7.4 in combination 
with 0.2M MgCl2 and 30% PEG 6000. pH optimization was 
6
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followed by a 30% PEG screen (ranging PEG 400 to PEG 
20000) with protein:condition solution ratios of (1:1, 1:1.5, and 
1:2). Pent AA with IP6 hits generally precipitated crystals 
within 7 days of setting up crystallization trays (Figure 7). 
 
 
Figure 7. Pent AA with IP6 crystallization using microbatch under 
oil. (A.) Initial crystal hit for ProComp conditions (0.2M 
Magnesium Chloride, 0.1M HEPES pH7, and 20% Polyethylene 
Glycol 6000) observed on 01-22-20. (B.) Crystal hit post-
protein:condition ratio/pH/precipitating agent optimization with 
conditions: 0.2M Magnesium Chloride, 0.1M HEPES pH 7.4, and 
30% Polyethylene Glycol 6000 observed on 02-07-20. Crystals 
observed under light microscopy and photographed. Pictures 




 Analysis of key binding regions in CA tubes provides 
novel information on capsid structure and stability. Molecules 
containing poly-glutamate stretches have been shown to interact 
with the centrally-charged pore region of capsid such as FEZ19. 
This indicates a key binding region for small stabilizing 
molecules. As expected, when the CA tubes were mutated with 
R18D, there was a loss of binding to PQBP1, a molecule 
containing similar glutamate stretches (Figure 3). Results 
indicate that we now know PQBP1 specifically targets the CA 
hexamer pore. Pelleting assays6 are currently in progress using 
mutant residues of PQBP1 to test which regions of PQBP1 
interact with CA hexamer pore (Figure 3). Further pelleting 
assays will be conducted with restriction factors of interest and 
small molecules of interest to characterize the capsid lattice 
structure.  
 Given that each capsid fullerene cone contains ~200 
hexamers, studying the hexamer structure presents opportunities 
to identify small molecule factors that may stabilize its presence 
in host organisms. IP6 is an essential HIV pocket factor that 
prevents capsid collapse with the six negatively charged 
phosphate groups stabilizing the positively charged arginine 
ring of hexamers2. Hex AA with IP6, CypA, and llama 
nanobody crystal hits from initial ProComp matrix screen (0.2M 
Sodium Acetate, 0.1M Sodium Citrate pH 5.5, 10% 
Polyethylene Glycol 4000) were successfully optimized as 
shown by the growth in size and density (Figure 4). Due to a 
variety of external factors, including crystal lattice order, 
molecular packing and beam intensity from x-ray 
crystallography, the diffraction data collected at NE-CAT 
beamline 24ID-C at the Advanced Photon Source was not high 
resolution. Lack of resolution could be attributed to CypA and 
llama nanobody creating too dynamic of a lattice to have solid 
packing and good order for data collection. Poly-E peptide was 
examined as a potential binding candidate to Hex AA due to 
having similar glutamate stretches as FEZ19 and PQBP1. High-
resolution diffraction data of Hex AA with poly-E peptide was 
obtained at 3.5 Å (Figure 5). Data is currently being processed 
for structural analysis. Poly-E peptide has a chain of glutamates 
that was thought to have high binding affinity to the central 
capsid pore. Our crystallization results indicated that poly-E 
peptide did indeed bind to the charged hexamer pore. This 
discovery aligns with prior studies where hexamer pore was 
shown to bind to poly-glutamate stretches9. Further studies 
include setting repeats of with Hex AA in its most optimized 
state with variations in pH, temperature, protein concentrations, 
and molecules present as all of these factors can play a role in 
the stability and crystal lattice formation. Small molecules of 
interest including, but not limited to: IP6, various dNTPs, CypA, 
7
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llama nanobody, and other phosphate moieties in combination 
with other matrix screens can be set up.  
 Each capsid fullerene cone contains 12 pentamers that 
have points of the highest stress due to being essential for the 
curvature of the cone. Due to this increased stress, regions in the 
pentamer could be where capsid initially breaks open to release 
its viral genome into the host. and thus presents an interesting 
target to study. U  a , a  d  a   a  
symmetry problem since lattices do not allow 5-fold symmetry 
to propagate. Currently, there are no structures of pentamers 
with small molecules and presents an interesting target for 
analysis. First, crystallization trays of the Apo-form of Pent AA 
were set up in order to understand baseline conditions that affect 
the stability and structure of them in solution (Figure 6). After 
setting up various matrix screens, it appeared that Pent AA was 
generally most stable in pH ranges between 6-7 with higher 
molecular weight precipitating agents (PEG 6000-8000) at a 20-
30% ratio. After months of trial and error with optimization, it 
is noteworthy that the crystals produced from Pent AA Apo 
generally remained the same size even after optimization of 
matrix screens, protein:condition solution, pH, and precipitating 
agent. The lack of crystal growth and density could be attributed 
to the lack of molecules present in solution and/or the pentamer 
structure inhibiting higher ordered lattice packing. CypA with 
llama nanobody could be used as cofactors to break the six-fold 
symmetry when bound to Hex AA4,5. CypA was a host factor 
that when combined to llama nanobody and Hex AA allowed 
for symmetry breaking and the visualization of molecular 
interactions in capsid hexamers. Pent AA with CypA presented 
a novel opportunity to characterize a potential interaction 
between them. After months of optimization from matrix 
screens, the most ordered crystals produced came from 
ProComp condition (0.1M MgCl2, 0.1M HEPES pH 7.5, and 
10% PEG 4000). Given that IP6 was a stabilizing molecule for 
Hex AA, Pent AA incubated with IP6 presented an interesting 
novel target to study (Figure 7). The most ordered Pent AA with 
IP6 crystals came from PACT condition (0.2M MgCl2, 0.1M 
HEPES pH 7.4, and 30% PEG 6000). Interestingly, when Pent 
AA was present with either CypA or IP6, it preferred conditions 
of magnesium chloride (0.1-0.2M MgCl2) and HEPES (pH 7.4-
7.5). The solution conditions between Pent AA CypA and Pent 
AA IP6 were in fact almost identical. Surprisingly, Pent AA 
with CypA took the longest time to produce crystals (~30 days) 
compared to Pent AA Apo or Pent AA IP6 (~6 days). Given that 
the crystallization trays tested were almost identical aside from 
the small molecules of interest, I expected the Pent AA crystals 
to all precipitate at relatively similar time periods. Being that 
microbatch under oil crystallization techniques allow for the 
slow evaporation of condition under oil, it is not unreasonable 
that crystals can be formed at later time periods due to varying 
evaporation rates that alter protein concentrations present.  
 Unfortunately, due to the COVID-19 pandemic, novel 
optimized Pent AA crystals, observed in late February, in Apo-
form, with IP6, and CypA could not be shot and analyzed using 
beam time. Future directions include the continued optimization 
of Hex AA and Pent AA crystals with higher resolution crystals 
analyzed using x-ray crystallography. Furthermore, in vitro 
fullerene capsid shells could be created and tested to understand 
the macromolecular stability of capsid. By obtaining diffraction 
patterns of capsid crystals, an electron density map and model 
of the molecular interactions can be created. By continuing to 
optimize crystals to achieve better resolutions, more precise 
models of the molecular interactions can be obtained. 
U a ,  d  ca  b  d  c a ac  ca d  
metastable condition and further understand how its domains 
are affected spatial and temporal for novel drug targeting.  
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